Filippo Miselli

1PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 21, 2020
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study.

Alessandro M Vannucchi, Benedetta Sordi, Alessandro Morettini

Pageof 1